Rua Bioscience Ltd
NZX:RUA

Watchlist Manager
Rua Bioscience Ltd Logo
Rua Bioscience Ltd
NZX:RUA
Watchlist
Price: 0.03 NZD Market Closed
Market Cap: 8.6m NZD
Have any thoughts about
Rua Bioscience Ltd?
Write Note
RUA
/
Cash Flow Statement
/
Capital Expenditures

Rua Bioscience Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rua Bioscience Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Rua Bioscience Ltd
NZX:RUA
Capital Expenditures
-NZ$1.2k
CAGR 3-Years
90%
CAGR 5-Years
69%
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Capital Expenditures
-NZ$569k
CAGR 3-Years
28%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Capital Expenditures
-NZ$8.6m
CAGR 3-Years
-19%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Capital Expenditures
-NZ$345.2k
CAGR 3-Years
-59%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Capital Expenditures
-NZ$532.5k
CAGR 3-Years
25%
CAGR 5-Years
-231%
CAGR 10-Years
N/A
No Stocks Found

Rua Bioscience Ltd
Glance View

Market Cap
8.6m NZD
Industry
Pharmaceuticals

Rua Bioscience Ltd. operates as a pharmaceutical company that develops medical cannabis products. The company is headquartered in Gisborne, Gisborne. The company went IPO on 2020-10-22. The firm operate in the medicinal cannabis sector commercially and is focused on producing cannabinoid derived medicines. The firm is also focusing on cultivating and developing quality-assured medicinal cannabis as active pharmaceutical ingredients.

RUA Intrinsic Value
0.001 NZD
Overvaluation 96%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Rua Bioscience Ltd's Capital Expenditures?
Capital Expenditures
-1.2k NZD

Based on the financial report for Jun 30, 2024, Rua Bioscience Ltd's Capital Expenditures amounts to -1.2k NZD.

What is Rua Bioscience Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
69%

Over the last year, the Capital Expenditures growth was 98%. The average annual Capital Expenditures growth rates for Rua Bioscience Ltd have been 90% over the past three years , 69% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.